This Lecture Series will address and foster dialogue on global biomedical and regulatory issues, challenges and advances, with a forward-looking perspective on the themes of improving health systems and policies, enhancing biomedical innovation, and promoting access to good, safe and effective health products.
The 2021 inaugural Sir Alasdair Breckenridge Lecture was delivered by Professor Sir Jeremy Farrar, Director of the Wellcome Trust on the topic of “Science, Innovation and Society”. Sir Jeremy highlighted the importance and inter-connectedness of these three themes in the context of COVID-19. This is very apt with the Lecture Series being launched during the pandemic as a hybrid event with a small in-person gathering in Singapore and a large online international audience.
Following the inaugural lecture, Dr Margaret Hamburg, Chair of CoRE introduced the Alasdair Breckenridge Fund which will provide study awards for regulatory and healthcare professionals from South-East Asia and Asia-Pacific national regulatory authorities and ministries of health to attend courses tenable at CoRE.
In keeping with Sir Alasdair’s interest in promoting regulatory capacity building and professional excellence, the lecture will be organised in conjunction with the graduation ceremony of CoRE’s Health Products Regulation Graduate Certificate Programme, to celebrate the achievements of each graduating cohort and affirm their commitment to pursuing regulatory excellence.
Through these initiatives, Sir Alasdair’s legacy will continue to make a lasting impact on future generations of regulatory science and health professionals in and around the Asia-Pacific.